5-[[6-[4-(dimethylamino)-1-imidazol-1-ylbutyl]-1,3-benzothiazol-2-yl]amino]-2,2-dimethyl-5-oxopentanoic acid
C23H31N5O3S — CID 123281484
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[6-[4-(dimethylamino)-1-imidazol-1-ylbutyl]-1,3-benzothiazol-2-yl]amino]-2,2-dimethyl-5-oxopentanoic acid
5-[[6-[4-(dimethylamino)-1-imidazol-1-ylbutyl]-1,3-benzothiazol-2-yl]amino]-2,2-dimethyl-5-oxopentanoic acid (PubChem CID 123281484) has the molecular formula C23H31N5O3S and a molecular weight of 457.60 g/mol. Its IUPAC name is 5-[[6-[4-(dimethylamino)-1-imidazol-1-ylbutyl]-1,3-benzothiazol-2-yl]amino]-2,2-dimethyl-5-oxopentanoic acid.
Molecular Properties
| Compound Name | 5-[[6-[4-(dimethylamino)-1-imidazol-1-ylbutyl]-1,3-benzothiazol-2-yl]amino]-2,2-dimethyl-5-oxopentanoic acid |
|---|---|
| PubChem CID | 123281484 |
| Molecular Formula | C23H31N5O3S |
| Molecular Weight | 457.60 g/mol |
| Exact Mass | 457.21 |
| IUPAC Name | 5-[[6-[4-(dimethylamino)-1-imidazol-1-ylbutyl]-1,3-benzothiazol-2-yl]amino]-2,2-dimethyl-5-oxopentanoic acid |
| SMILES | CN(C)CCCC(c1ccc2nc(NC(=O)CCC(C)(C)C(=O)O)sc2c1)n1ccnc1 |
| InChI | InChI=1S/C23H31N5O3S/c1-23(2,21(30)31)10-9-20(29)26-22-25-17-8-7-16(14-19(17)32-22)18(6-5-12-27(3)4)28-13-11-24-15-28/h7-8,11,13-15,18H,5-6,9-10,12H2,1-4H3,(H,30,31)(H,25,26,29) |
| InChIKey | VJJVMOQGHGGJBY-UHFFFAOYSA-N |
| XLogP | 4.25 |
| TPSA | 100.35 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.60 |
| LogP ≤ 5 | 4.25 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123281484 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.